71 West Capital Partners’s AstraZeneca AZN Stock Holding History

71 West Capital Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Buy	5,676 +2,793	+97%	+$525K	0.04%	134
2026 Q1	$558K	Buy	2,883 +1,729	+150%	+$333K	0.02%	153
2025 Q4	$212K	Buy	+1,154	New	+$202K	0.01%	253

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

71 West Capital Partners's AZN Position: Q2 2026 in Review

71 West Capital Partners increased its AstraZeneca (AZN) stake by 97% in Q2 2026, buying an estimated $525K and bringing the position to 5,676 shares worth $1.06M. The position accounts for 0.04% of the portfolio, ranked #134.

71 West Capital Partners first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

71 West Capital Partners held 5,676 shares of AstraZeneca worth $1.06M as of Q2 2026.
71 West Capital Partners bought 2,793 AstraZeneca shares in Q2 2026, an estimated $525K.
AstraZeneca made up 0.04% of 71 West Capital Partners's portfolio in Q2 2026, its #134 holding.
71 West Capital Partners first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on 71 West Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.